A corona vaccine from the British company Astrazeneca is already being widely tested in Brazil. A contract is now set to ensure the production of 100 million vaccination units.
Brasília (dpa) – The Brazilian research institute Fiocruz, the Brazilian Ministry of Health and the British pharmaceutical company Astrazeneca have signed a first contract for the production of millions of doses of a possible vaccine against the coronavirus.
The document formed the basis for technology transfer and the production of 100 million doses of vaccine against Covid-19 if protection against infection by the vaccine should be demonstrated, the Ministry of Health in Brasília said in a statement on Friday evening (local time). With.
An Astrazeneca corona vaccine, developed by researchers at Oxford University, is already being tested in Brazil in the crucial third phase. The effectiveness of a substance is determined on a larger group of people.
Brazil is currently one of the focal points of the corona pandemic besides the United States. More than 2.5 million people have become infected in the largest and most populous country in Latin America, and more than 90,000 patients have died from Covid-19 lung disease. The actual numbers are likely to be much higher, also because the country tests very little.
In many places the curve is still rising, which is important for the crucial phase of the vaccine test. Brazil also has research facilities such as the Fiocruz Institute, whose vaccine factory in the north zone of Rio is considered the largest in Latin America.
Almost 110 million doses of vaccine for the Brazilian public health system were produced here last year. Bio-Manguinhos also produces 80 percent of the world’s yellow fever vaccinations, according to the “G1” portal.